Objective To evaluate the possible involvement of JC virus (JCV) in the aetiology of multiple sclerosis (MS), through the comparison of DNA prevalences and viral loads of JCV in cerebrospinal fluid (CSF) of MS patients at the first demyelinating event and subjects suffering from other neurological diseases (OND).
Methods Seventy-three CSF samples (43 from MS patients at the first demyelinating event, and 30 from patients with OND) were collected; all MS cases were followed up from 1 to 6.7 years after they were diagnosed with clinically definite MS. DNA was extracted and analysed by real-time PCR for the detection of JCV genomes.
Results We found JCV DNA in the CSF of two MS patients (4.7%) with a mean viral load of 2.1 and 6.7 copies/mL of CSF. Among the patients of the OND group we did not find any positive sample. We did not find any difference in the course of the disease between MS patients with and without JCV genomes in their CSF along the follow up.
Conclusion JCV seems to be only a bystander in the pathology of MS, and the presence of cell-free viral particles could be related to the immunological activation of the disease, mainly during relapses. Multiple Sclerosis 2007; 13: 590-595. http://msj.sagepub.com
Kwak EJ, Vilchez RA, Randhawa P., Shapiro R., Butel JS, Kusne S.Pathogenesis and management ofl polyomavirus inflection in transplant recipients . Clin InfectDis2002; 35: 1081-87.
2.
Dorries K.Molecular biology and pathogenesis ofl human polyomavirus inflections. Dev Biol Stand1998; 94: 71-79.
3.
Ferrante P, Omodeo-Zorini E., Caldarelli-Stefano R., Mediati M., Fainardi E., Granieri E. et al. Detection ofl JC virus DNA in cerebrospinal fluid flrom multiple sclerosis patients. Mult Scler1998; 4: 49-54.
4.
Kurtzke JFMS epidemiology world wide. One view ofl current status. Acta Neurol Scand Suppl1995; 161: 23-33.
5.
Wolfson C.Multiple sclerosis and antecedent inflections. Epidemiology2001; 12: 298-99.
6.
Gordon J., Khalili K.The human polyomavirus, JCV, and neurological diseases. Int J Mol Med1998; 1: 647-55.
7.
Kleinschmidt-DeMasters BK, Tyler KLProgressive multiflocal leukoencephalopathy complicating treatment with natalizumab and interfleron beta-1a flor multiple sclerosis. N Engl J Med2005; 353: 369-74.
8.
Langer-Gould A., Atlas SW, Green AJ, Bollen AW, Pelletier D.Progressive multiflocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med2005; 353: 375-81.
9.
Mischitelli M., Fioriti D., Videtta M., Degener M., Antinori A., Cinque P. et al. Investigation on the role ofl cell transcriptional flactor Sp1 and HIV-1 TAT protein in PML onset or development . J Cell Physiol2005; 204: 913-18.
10.
Watzinger F. , Suda M., Preuner S., Baumgartinger R., Ebner K., Baskova L. et al. Real-time quantitative PCR assays flor detection and monitoring ofl pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol2004; 42: 5189-98.
11.
Frisque RJ, White FAThe molecular biology ofl JC virus, causative agent ofl progressive multiflocal leukoencephalopathy. In Roos RP ed. Molecular neurovirology. Humana Press Inc., 1992: 25-158.
12.
Berger JRProgressive multiflocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate flrequency ofl the illness relative to other immunosuppressive conditions. J Neurovirol2003; 9: 38-41.
13.
Kitamura T. , Sugimoto C., Kato A., Ebihara H., Suzuki M., Taguchi F. et al. Persistent JC virus (JCV) inflection is demonstrated by continuous shedding ofl the same JCV strains. J Clin Microbiol1997; 35: 1255-57.
14.
Tominaga T. , Yogo Y., Kitamura T., Aso Y.Persistence ofl archetypal JC virus DNA in normal renal tissue derived flrom tumor-bearing patients. Virology1992; 186: 736-41.
15.
Hori R., Murai Y., Tsuneyama K., Abdel-Aziz HO, Nomoto K., Takahashi H. et al. Detection ofl JC virus DNA sequences in colorectal cancers in Japan. Virchows Arch2005; 447: 723-30.
16.
Dubois V., Lafon ME, Ragnaud JM, Pellegrin JL, Damasio F., Baudouin C. et al. Detection ofl JC virus DNA in the peripheral blood leukocytes ofl HIV-inflected patients. AIDS1996; 10: 353-58.
17.
Del Valle L , Enam S., Lara C., Miklossy J., Khalili K., Gordo J.Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome. J Virol2004; 78: 3462-69.
18.
Ricciardiello L., Laghi L., Ramamirtham P., Chang CL, Chang DK, Randolph AE et al. JC virus DNA sequences are flrequently present in the human upper and lower gastrointestinal tract. Gastroenterology2000; 119: 1228-35.
19.
Rencic A., Gordon J., Otte J., Curtis M., Kovatich A., Zoltick P. et al. Detection ofl JC virus DNA sequence and expression ofl the viral oncoprotein, tumor antigen, in brain ofl immunocompetent patient with oligoastrocytoma . Proc Natl Acad Sci U S A1996; 93: 7352-57.
20.
Yousry TA, Major EO, Ryschkewitsch C., Fahle G., Fischer S., Hou J. et al. Evaluation ofl patients treated with Natalizumab flor progressive multiflocal leukoencephalopathy. N Engl J Med2006; 354: 924-33.
21.
Behzad-Behbahani A., Klapper PE, Vallely PJ, Cleator GM, Bonington A.BKV-DNA and JCV-DNA in CSF ofl patients with suspected meningitis or encephalitis. Infection2003; 31: 374-78.
22.
Eggers C., Stellbrink HJ, Buhk T., Dorries K.Quantification ofl JC virus DNA in the cerebrospinal fluid ofl patients with human immunodeficiency virus-associated progressive multiflocal leukoencephalopathy - a longitudinal study. J Infect Dis1999; 180: 1690-94.
23.
Koralnik IJ, Boden D., Mai VX, Lord CI, Letvin NLJC virus DNA load in patients with and without progressive multiflocal leukoencephalopathy . Neurology1999; 52: 253-60.
24.
Yiannoutsos CT , Major EO, Curfman B., Jensen PN, Gravell M., Hou J. et al. Relation ofl JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multiflocal leukoencephalopathy. Ann Neurol1999; 45: 816-21.
25.
Garcia De Viedma D., Diaz Infantes M., Miralles P., Berenguer J., Marin M., Munoz L. et al. JC virus load in progressive multiflocal leukoencephalopathy: analysis ofl the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume ofl neurological lesions. Clin InfectDis2002; 34: 1568-75.
26.
Bossolasco S., Calori G., Moretti F., Boschini A., Bertelli D., Mena M. et al. Prognostic significance ofl JC virus DNA levels in cerebrospinal fluid ofl patients with HIV-associated progressive multiflocal leukoencephalopathy. Clin InfectDis2005; 40: 738-44.
27.
Rotola A., Merlotti I., Caniatti L., Caselli E., Granieri E., Tola MR et al. Human herpesvirus 6 inflects the central nervous system ofl multiple sclerosis patients in the early stages ofl the disease. Mult Scler2004; 10: 348-54.
28.
Maggi F., Fornai C., Vatteroni ML, Siciliano G., Menichetti F., Tascini C. et al. Low prevalence ofl TT virus in the cerebrospinal fluid ofl viremic patients with central nervous system disorders. J Med Virol2001; 65: 418-22.
29.
Tejada-Simon MV, Zang Ycq, Hong J., Rivera VM, Killian JM, Zhang JZDetection ofl viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol2002; 76: 6147-54.
30.
Ablashi DV, Lapps W., Kaplan M., Whitman JE, Richert JR, Pearson GRHuman herpesvirus-6 (HHV-6) inflection in multiple sclerosis: a preliminary report. Mult Scler1998; 4: 490-96.
31.
Puccioni-Sohler M., Rios M., Carvalho SM, Goncalves RR, Oliveira C., Correa RB et al. Diagnosis ofl HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index. Neurology2001; 57: 725-27.
32.
Achiron A., Miron S., Shoenfeld Y.Does the flap ofl a butterfly's wings in Brazil set oflfl a tornado in Texas? The JC virus story in multiple sclerosis. Isr Med Assoc J2005; 7: 283-85.
33.
Stoner GLImplications ofl progressive multiflocal leukoencephalopathy and JC virus flor the etiology ofl MS. Acta Neurol Scand1991; 83: 20-33.
